tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MCRB Stock Latest News

Seres Therapeutics presents expanded SER-155 biomarker data at ASCO meeting
The FlySeres Therapeutics presents expanded SER-155 biomarker data at ASCO meeting
1M ago
MCRB
Buy Rating Maintained for Seres Therapeutics Amid Promising SER-155 Developments and Financial Stability
PremiumRatings
Buy Rating Maintained for Seres Therapeutics Amid Promising SER-155 Developments and Financial Stability
2M ago
MCRB
Seres Therapeutics downgraded to Neutral from Buy at Chardan
PremiumThe Fly
Seres Therapeutics downgraded to Neutral from Buy at Chardan
2M ago
MCRB
Seres Therapeutics Reports Positive Q1 2025 Results
PremiumCompany Announcements
Seres Therapeutics Reports Positive Q1 2025 Results
2M ago
MCRB
Seres Therapeutics’ Positive Earnings Call: Progress and Challenges
PremiumCompany Announcements
Seres Therapeutics’ Positive Earnings Call: Progress and Challenges
2M ago
MCRB
Seres Therapeutics Advances SER-155 Program with FDA Submission
PremiumCompany AnnouncementsSeres Therapeutics Advances SER-155 Program with FDA Submission
2M ago
8K
MCRB
Seres Therapeutics reports Q1 EPS $3.75, consensus $1.97
Premium
The Fly
Seres Therapeutics reports Q1 EPS $3.75, consensus $1.97
2M ago
MCRB
MCRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MCRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
MCRB
Seres Therapeutics presents three posters at DDW Conference
PremiumThe Fly
Seres Therapeutics presents three posters at DDW Conference
2M ago
MCRB
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
DDC
PLX
Seres Therapeutics trading resumes
PremiumThe Fly
Seres Therapeutics trading resumes
2M ago
MCRB
Seres Therapeutics trading halted, volatility trading pause
PremiumThe Fly
Seres Therapeutics trading halted, volatility trading pause
2M ago
MCRB
Seres Therapeutics trading halted, news pending
PremiumThe FlySeres Therapeutics trading halted, news pending
2M ago
MCRB
Upcoming Stock Splits This Week (April 21 to April 25) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (April 21 to April 25) – Stay Invested
2M ago
DDC
YHC
Seres Therapeutics Approves Reverse Stock Split Plan
Premium
Company Announcements
Seres Therapeutics Approves Reverse Stock Split Plan
3M ago
8K
MCRB
Promising Developments and Financial Backing Bolster Seres Therapeutics’ Buy Rating
PremiumRatings
Promising Developments and Financial Backing Bolster Seres Therapeutics’ Buy Rating
4M ago
MCRB
Seres Therapeutics Advances SER-155 Program with FDA Support
PremiumCompany Announcements
Seres Therapeutics Advances SER-155 Program with FDA Support
4M ago
MCRB
Seres Therapeutics Earnings Call: Progress Amid Uncertainty
PremiumCompany Announcements
Seres Therapeutics Earnings Call: Progress Amid Uncertainty
4M ago
MCRB
Seres Therapeutics: Strategic Developments and Promising Clinical Data Justify Buy Rating
PremiumRatings
Seres Therapeutics: Strategic Developments and Promising Clinical Data Justify Buy Rating
4M ago
MCRB
Seres Therapeutics Reports 2024 Financial Results and SER-155 Progress
PremiumCompany AnnouncementsSeres Therapeutics Reports 2024 Financial Results and SER-155 Progress
4M ago
8K
MCRB
Seres Therapeutics reports FY24 EPS (81c), consensus (20c)
Premium
The Fly
Seres Therapeutics reports FY24 EPS (81c), consensus (20c)
4M ago
MCRB
Seres Therapeutics announces anticipated upcoming milestones
Premium
The Fly
Seres Therapeutics announces anticipated upcoming milestones
4M ago
MCRB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >